University of Minnesota: Tobacco Use Disorder trials

The registry lists 30 Tobacco Use Disorder studies with University of Minnesota as lead sponsor. 1 are open to participants now and 20 have results posted.

Phase 1 1Phase 2 8Phase 3 3Phase 4 1No phase 19(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Quit With Sense: Using Mindful Smoking and Wearable Device for Smoking CessationNot yet recruitingNCT07789496Not applicable
• Effect of Banning Menthol Flavorant on Cigarette and E-Cigarette UseCompletedNCT03402243Not applicableResults posted
• Effect of a Non-Invasive Brain Stimulation Technique on Smoking Cessation BehaviorsCompletedNCT03386253Not applicableResults posted
• Impact of Very Low Nicotine Content Cigarettes in a Complex MarketplaceCompletedNCT03272685Phase 3Results posted
• Menthol Flavored E-cigarette Use During a Simulated Ban of Menthol CigarettesCompletedNCT03164668Not applicableResults posted
• Medicinal Nicotine for Preventing Cue Induced CravingCompletedNCT02347605Not applicableResults posted
• Smoking Cessation in Menthol Flavored Cigarette SmokersCompletedNCT02342327Not applicableResults posted
• Novel Medication as a Potential Smoking Cessation AidCompletedNCT02265367Not applicableResults posted
• Smoking, Sex Hormones, and PregnancyCompletedNCT01811225Phase 2Results posted
• Progesterone & Postpartum Relapse to SmokingCompletedNCT01798394Not applicableResults posted
• Medicinal Nicotine for Preventing Stress Induced Craving and Withdrawal SymptomsCompletedNCT01522963Not applicableResults posted
• Novel Determinants and Measures of Smokeless Tobacco Use: Study 1CompletedNCT01067586Results posted
• Innovative Interventions for Smoking CessationCompletedNCT01050569Phase 2Results posted
• Human Laboratory Study of Varenicline and Bupropion for Nicotine DependenceCompletedNCT00749658Phase 2/3Results posted
• Evaluation of Oral Tobacco as a Harm Reduction Method for SmokersCompletedNCT00711100Not applicableResults posted
• Efficacy of Oral Tobacco Products Compared to a Medicinal NicotineCompletedNCT00710034Phase 2Results posted
• Human Laboratory Study Of Varenicline in SmokersCompletedNCT00709696Not applicableResults posted
• Phenethyl Isothiocyanate in Preventing Lung Cancer in SmokersCompletedNCT00691132Phase 2Results posted
• Health Effects of SLT, Cigarette Smoking, and New Tobacco ProductsCompletedNCT00469079Phase 2Results posted
• Effect of Paroxetine on Smokers' Cardiovascular Response to Stress - 1CompletedNCT00218439Not applicableResults posted
• Comparison Across Treatment Conditions to Reduce Smokeless Tobacco UseCompletedNCT00218296Phase 2Results posted
• Progesterone and Atomoxetine for Cocaine CessationWithdrawnNCT01741376Not applicable
• Deuterated Phenanthrene Tetraol in Smokers Who Are at High Risk For Lung CancerCompletedNCT01673711
• Promoting Home Smoking Restrictions: Biomarker Feedback to Smoking and Non-Smoking AdultsCompletedNCT01497158Not applicable
• Family-Skills Training to Prevent Tobacco and Other Substance Use in Latino YouthCompletedNCT01442753Not applicable
• Novel Determinants and Measures of Smokeless Tobacco Use: Study 2CompletedNCT01067599Not applicable
• Study of Bupropion Versus Bupropion + Naltrexone for Smoking CessationStatus unknownNCT00419731Phase 2/3
• Assessing the Link Between Smoke Carcinogen Biomarkers and Lung Cancer Risk - 1CompletedNCT00218179
• Tobacco Cessation in Postmenopausal Women (Part II) - 2CompletedNCT00061074Phase 1
• Tobacco Cessation in Postmenopausal Women (Part I) - 1CompletedNCT00061061Phase 4